WIRB-Copernicus Group to Co-present Nine Sessions at Public Responsibility in Medicine and Research Conference
PRINCETON, N.J., Nov. 13, 2015 – WIRB-Copernicus Group® (WCG™), the world’s largest provider of regulatory and ethical review services and software to support clinical research, today announced that six of its thought leaders are presenting nine sessions at the Public Responsibility in Medicine & Research (PRIM&R) Advancing Ethical Research (AER) 2015 Conference, which is being held Nov. 12-15 in Boston, MA.
“WCG is exceptional in that our team includes professionals hailing from diverse scientific and medical backgrounds, with unparalleled achievements in the field of human subject protections and institutional biosafety administration,” said WCG Chief Medical Officer Lindsay McNair, MD, MPH, MSBioethics. “Through forums such as PRIM&R, we are able to share our knowledge and experience with other research professionals, thus helping to increase safeguards for research participants.”
The following PRIM&R sessions will be co-hosted by WCG experts:
Friday, Nov. 13
2:30 – 3:45 p.m.
A12 – “Unanticipated Problems and Adverse Events: A Practical Approach for IRBs” – Jeffrey Cooper, MD, MMM, WCG’s vice president for process and strategic improvement
4:00 – 5:15 p.m.
B2 – “A Dialogue with SACHRP” – David G. Forster, JD, MA, CIP, WCG chief compliance officer
B13 – “Evaluating Members, Chairs, and Staff: What Works, What Doesn’t?” – Yvonne K. Higgins, MS, CIP, WCG senior consultant
B15 – “Is Facebook Hurting Your Study? Ethical and Study Integrity Concerns When Participants Use Social Media” – Dr. Lindsay McNair
Saturday, Nov. 14
11:15 a.m. – 1:45 p.m.
C9 – “Determining the Effectiveness of Community Engagement in Global Health Research” – David A. Borasky, Jr., MPH, CIP, vice president of quality management, Copernicus Group IRB
C21 – “Novel Methods, Approaches, and Tools for QA/QI, Including Electronic Systems and Technology” – Dr. Jeffrey Cooper
D17 – “Scientific Aspects of Study Design: A Primer for Non-Scientists” – Dr. Lindsay McNair
Sunday, Nov. 15
11:15 a.m. – 12:30 p.m.
E8 – “Humanitarian Use Device Designation and Humanitarian Device Exemptions: The Role of the IRB” – David G. Forster
E13 – “The Work of the IRB Chair: Beyond the Meeting” – Patience B. Stevens, MD, MPH, CIP, IRB vice chairperson, Copernicus Group IRB
WCG experts will also be available to answer attendee questions in the exhibit hall. Two of WCG’s companies, Western Institutional Review Board® (WIRB) and IRBNet are sponsors of the conference, and will have a presence at booths #218 and #222, respectively. Founded in 1968, WIRB was the first independent review board and the pioneer of ethical review. It is now the trusted partner for more than 1,400 institutions in the U.S. alone. IRBNet provides compliance and research oversight solution for institutions, supporting more than 2,500 research sites and review boards and more than 125,000 research professionals.
For further information about the PRIM&R AER conference, please visit http://www.primr.org/aer15.
About WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world’s largest provider of regulatory and ethical solutions for clinical research. The company provides Institutional Review Board (IRB) and Institutional Biosafety Committee (IBC) reviews, and Human Research Protection (HRP), Good Clinical Practice (GCP) and Biosafety consulting services. Its technology offerings include IRB workflow management solutions (IRBNet), clinical trial management software for sponsors and contract research organizations (ePharmaSolutions), and Part-11 compliant online learning solutions for research professionals (WCG Academy).
The pioneer of independent ethical oversight, WCG continues to drive progress in the clinical research space. WCG empowers clients to accelerate life-saving advancements, while ensuring that the risks of progress never outweigh the value of human life.
For more information, please visit www.wcgclinical.com or follow us on Twitter @WCGClinical.